Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Bluegreen who wrote (16529)	12/22/2003 12:37:07 PM
From: aknahow	Read Replies (2) \| Respond to of 17367

I take the request for more info to mean more trial generated information. Not always the case but remember Castello was very clear in saying they would not do another trial. Well who asked them to? The FDA. More info request are hard to deal with because, obviously the trials were the major source of info and all that has been submitted to the FDA. How does one now give them more? They already have the trial info. They have now asked for more. They can deny they asked for more trials, because they haven't yet what do you do> Tell shareshoders about Basian analysis and wait for them to figure out how to spell it and punt it around, but seriously, what do you do? You say the probe info can be used. Great! Let's see what happens. I will believe it when I see it.